5.01 May 2024Formulation scientistFormer employeeAndover, MARecommendCEO approvalBusiness outlookProsthis is a high payConsthis company no longer existsShow more
5.029 July 2023Senior managerFormer employeeRecommendCEO approvalBusiness outlookProsGreat company, innovative cancer immunotherapy platformConsSuffered the fate of many biotech startups in a tough investment envirnomentShow moreHelpfulShare
4.04 Jan 2025ScientistFormer employeeRecommendCEO approvalBusiness outlookProsCollaboration between different departments for common goalConsLeadership didn’t always agree with each otherShow moreHelpfulShare